Evoq Remedies Ltd Stock Price Today (NSE: EVOQ)
Fundamental Score
Evoq Remedies Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Evoq Remedies Ltd share price today is ₹3.21, down 0.31% on NSE/BSE as of 19 June 2026. Evoq Remedies Ltd (EVOQ) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of ₹7.99 (Cr). The 52-week high for EVOQ share price is ₹6.11 and the 52-week low is ₹2.27. At a P/E ratio of 4.54x, EVOQ is currently trading below its industry average P/E of 35.45x. The company has a Return on Equity (ROE) of 0.26% and a debt-to-equity ratio of 0.00.
Evoq Remedies Ltd Share Price Chart — NSE/BSE Historical Performance
Evoq Remedies Ltd share price chart: -6.75% return over the past month. 52-week high ₹6.11, 52-week low ₹2.27.
Evoq Remedies Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹3.24 | ₹3.24 | ₹3.21 | ₹3.21 | 20.00K (Cr) | |
| ₹3.20 | ₹3.28 | ₹3.11 | ₹3.22 | 52.00K (Cr) | |
| ₹3.30 | ₹3.68 | ₹3.15 | ₹3.22 | 72.00K (Cr) | |
| ₹3.61 | ₹3.61 | ₹3.32 | ₹3.59 | 32.00K (Cr) | |
| ₹3.48 | ₹3.50 | ₹3.48 | ₹3.49 | 20.00K (Cr) | |
| ₹3.45 | ₹3.45 | ₹3.30 | ₹3.31 | 20.00K (Cr) | |
| ₹3.45 | ₹3.45 | ₹3.45 | ₹3.45 | 4.00K (Cr) | |
| ₹3.40 | ₹3.50 | ₹3.40 | ₹3.50 | 12.00K (Cr) | |
| ₹3.26 | ₹3.29 | ₹3.08 | ₹3.22 | 64.00K (Cr) | |
| ₹3.26 | ₹3.30 | ₹3.16 | ₹3.25 | 36.00K (Cr) |
Evoq Remedies Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹3.20 | ₹3.28 | ₹3.11 | ₹3.21 | +0.31% | |
| ₹3.45 | ₹3.75 | ₹3.08 | ₹3.22 | -6.67% | |
| ₹2.50 | ₹4.20 | ₹2.27 | ₹3.42 | +36.80% | |
| ₹2.85 | ₹3.20 | ₹2.30 | ₹2.30 | -19.30% | |
| ₹2.91 | ₹3.40 | ₹2.86 | ₹3.00 | +3.09% | |
| ₹3.04 | ₹3.50 | ₹2.65 | ₹2.97 | -2.30% | |
| ₹3.02 | ₹3.94 | ₹2.60 | ₹3.19 | +5.63% | |
| ₹4.67 | ₹4.70 | ₹3.05 | ₹3.17 | -32.12% | |
| ₹4.05 | ₹6.11 | ₹3.85 | ₹4.91 | +21.23% | |
| ₹3.07 | ₹4.69 | ₹3.07 | ₹3.95 | +28.66% | |
| ₹3.42 | ₹4.13 | ₹2.95 | ₹3.08 | -9.94% | |
| ₹5.24 | ₹5.24 | ₹3.54 | ₹3.58 | -31.68% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Evoq Remedies Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Evoq Remedies Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of EVOQ across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Attractive Valuation (P/E: 4.54 vs Industry: 35.45)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (103.09%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.26%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.35%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-8.24%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Weak Earnings Growth (-67.52% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-40.33 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Low Promoter Commitment (11.21%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Evoq Remedies Ltd vs Trading & Distributors Peers
Peer Comparison - Trading & Distributors
Compare Evoq Remedies Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Evoq Remedies LtdEvoq Remedies L...Selected✓ EVOQ • 543500 | 20.3/100 | ₹3.21₹3 | ₹7.99₹7.99 | 4.54Average 4.5 Average | 0.26%Poor 0.26% Poor | 0.35%Poor 0.35% Poor | 0.00Excellent 0.0 Excellent | — — | 5.33%Good 5.33% Good | 0.00% |
Redington LtdRedington Ltd... REDINGTON • 532805 | 58.5/100 | ₹222.80₹223 | ₹22049.92₹22049.92 | 16.14Average 16.1 Average | 14.39%Average 14.39% Average | 18.90%Good 18.90% Good | 0.29Excellent 0.3 Excellent | 17.72%Excellent 17.72% Excellent | 14.06%Good 14.06% Good | 2.41% |
MMTC LtdMMTC Ltd... MMTC • 513377 | 32.1/100 | ₹65.99₹66 | ₹8949.04₹8949.04 | 127.30Average 127.3 Average | 5.87%Poor 5.87% Poor | 7.70%Poor 7.70% Poor | 0.02Excellent 0.0 Excellent | 19.08%Excellent 19.08% Excellent | -86.52%Poor -86.52% Poor | 0.00% |
MSTC LtdMSTC Ltd... MSTCLTD • 542597 | 63.7/100 | ₹438.75₹439 | ₹3458.41₹3458.41 | 15.65Average 15.7 Average | 28.37%Excellent 28.37% Excellent | 29.26%Excellent 29.26% Excellent | 0.17Excellent 0.2 Excellent | 15.18%Excellent 15.18% Excellent | -24.06%Poor -24.06% Poor | 8.24% |
BN Holdings LtdBN Holdings Ltd... BNHOLDINGS • 526125 | 24.7/100 | ₹404.70₹405 | ₹3333.57₹3333.57 | 49.50Average 49.5 Average | 26.05%Excellent 26.05% Excellent | 27.44%Excellent 27.44% Excellent | 0.20Excellent 0.2 Excellent | — — | — — | 0.00% |
Vintage Coffee And Beverages IncVintage Coffee ... VINCOFE • 538920 | 11.1/100 | ₹154.05₹154 | ₹2132.64₹2132.64 | 35.45Average 35.5 Average | 17.05%Good 17.05% Good | 15.42%Good 15.42% Good | 0.17Excellent 0.2 Excellent | — — | — — | 0.06% |
TCC Concept LtdTCC Concept Ltd... TCC • 512038 | 34.8/100 | ₹379.00₹379 | ₹1813.06₹1813.06 | 38.36Average 38.4 Average | 9.28%Poor 9.28% Poor | 11.83%Average 11.83% Average | 0.05Excellent 0.1 Excellent | — — | — — | 0.00% |
Euro Asia Exports LtdEuro Asia Expor... EUROASIA • 530929 | 66.6/100 | ₹637.25₹637 | ₹1297.46₹1297.46 | 518.98Average 519.0 Average | 87.02%Excellent 87.02% Excellent | 82.72%Excellent 82.72% Excellent | 0.00Excellent 0.0 Excellent | 158.76%Excellent 158.76% Excellent | 66.77%Excellent 66.77% Excellent | 0.00% |
41.9/100 | ₹18.76₹19 | ₹1111.34₹1111.34 | 402.66Average 402.7 Average | 1.24%Poor 1.24% Poor | 2.46%Poor 2.46% Poor | 0.06Excellent 0.1 Excellent | 61.76%Excellent 61.76% Excellent | 35.83%Excellent 35.83% Excellent | 0.00% | |
Yamuna Syndicate LtdYamuna Syndicat... YSL • 540980 | 32.3/100 | ₹30300.00₹30300 | ₹1021.99₹1021.99 | 11.71Average 11.7 Average | 9.31%Poor 9.31% Poor | 9.39%Poor 9.39% Poor | 0.00Excellent 0.0 Excellent | 10.82%Good 10.82% Good | 4.86%Average 4.86% Average | 1.50% |
Oswal Agro Mills LtdOswal Agro Mill... OSWALAGRO • 500317 | 62.3/100 | ₹45.83₹46 | ₹811.32₹811.32 | 6.43Average 6.4 Average | 12.62%Average 12.62% Average | 16.29%Good 16.29% Good | 0.00Excellent 0.0 Excellent | 28.35%Excellent 28.35% Excellent | 61.75%Excellent 61.75% Excellent | 0.00% |
Top Trading & Distributors Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Redington Ltd share price22049.92 Cr
- MMTC Ltd share price8949.04 Cr
- MSTC Ltd share price3458.41 Cr
- BN Holdings Ltd share price3333.57 Cr
- Vintage Coffee And Beverages Inc share price2132.64 Cr
Evoq Remedies Ltd PE Ratio History
Historical price-to-earnings ratio for EVOQ — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.33 | ₹7.80 | 23.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Evoq Remedies Ltd Quarterly Performance
Latest quarterly metrics for EVOQ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
103.09%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
5.33%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Evoq Remedies Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for EVOQ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Evoq Remedies Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Evoq Remedies Ltd (EVOQ) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Evoq Remedies Ltd
About EVOQ (Evoq Remedies Ltd)
Evoq Remedies Ltd is a dynamic player in the Indian trading and distribution landscape, specializing in pharmaceutical solutions and high-quality castor oil products. As a prominen...t commission agent, EVOQ bridges the gap between manufacturers and consumers, facilitating seamless transactions and ensuring efficient market access for a diverse range of pharmaceutical products. The company prides itself on its robust network and deep understanding of the Indian pharmaceutical market, enabling it to provide invaluable services to both suppliers and customers. Through strategic partnerships and a commitment to ethical business practices, EVOQ has established itself as a trusted intermediary, consistently delivering value and fostering sustainable growth within the industry. Beyond its role as a trading and commission agent, Evoq Remedies Ltd operates a sophisticated manufacturing and distribution arm, focused on the production and global export of premium castor oil derivatives. The company's state-of-the-art facilities are equipped to produce a range of castor oil grades, including commercial grade, refined varieties, pale pressed grade, and the coveted first pressed degummed castor oil. These products find applications in various industries, from cosmetics and lubricants to pharmaceuticals and polymers. EVOQ maintains rigorous quality control standards throughout the manufacturing process, ensuring that its castor oil products meet the exacting requirements of its international clientele. EVOQ also demonstrates a commitment to sustainability by processing byproducts of the castor oil extraction process. The company manufactures and distributes castor oil and de-oiled cakes, as well as high-protein castor meals. This value-added approach minimizes waste and maximizes the utilization of resources, reflecting EVOQ's dedication to environmental responsibility. With its diverse portfolio, strategic market positioning, and unwavering commitment to quality and sustainability, Evoq Remedies Ltd is poised for continued success and expansion in the global trading and distribution arena.
Company Details
Key Leadership
Latest News
EVOQ Share Price: Frequently Asked Questions
What is the current share price of Evoq Remedies Ltd?
Evoq Remedies Ltd (EVOQ) trades at ₹3.21 on NSE and BSE. Market cap ₹7.99 (Cr). Educational data only.
What is the P/E ratio of Evoq Remedies Ltd?
Evoq Remedies Ltd has a P/E of 4.54x vs industry average 35.45x.
What is the Bull Run score for Evoq Remedies Ltd?
Evoq Remedies Ltd has a Bull Run score of 20.3/100 based on 25+ financial parameters.
Does Evoq Remedies Ltd pay dividends?
Evoq Remedies Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Evoq Remedies Ltd?
Evoq Remedies Ltd has ROE of 0.26%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Evoq Remedies Ltd?
Evoq Remedies Ltd has debt-to-equity of 0.00.
Is Evoq Remedies Ltd a good investment?
Bull Run gives Evoq Remedies Ltd a score of 20.3/100. This is not investment advice — consult a SEBI-registered advisor.